RHUMBLINE ADVISERS

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in WHWK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$112,342

+$98,491 QoQ

Shares Held

24,529

+158.6% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 78 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 23% Shared 0% None 77%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. WHWK ranks #271 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$112,342	24,529	+158.6%	Shares	Sole	2026-08-12
2024-06-30	$13,851	9,487	-62.6%	Shares	Sole	2024-08-01
2024-03-31	$59,403	25,386	+2.4%	Shares	Sole	2024-05-09
2023-12-31	$50,089	24,797	0.0%	Shares	Sole	2024-02-08
2023-09-30	$120,017	24,797	+5.3%	Shares	Sole	2023-11-09
2023-06-30	$161,068	23,548	+22.0%	Shares	Sole	2023-08-08
2023-03-31	$139,753	19,303	+4.4%	Shares	Sole	2023-05-11
2022-12-31	$237,213	18,489	+2.3%	Shares	Sole	2023-02-14
2022-09-30	$255,258	18,065	+6.3%	Shares	Sole	2022-11-10
2022-06-30	$209,390	16,996	—	Shares	Sole	2022-08-11
No filing history on record for this holder in this stock.